The Patent Finder

Histogen, Inc.

Also on record
Records under this name other than patents Histogen, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Histogen, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,257,947Extracellular matrix compositions produced under hypoxic culture conditions
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 8,524,494Low Oxygen Tension and BFGF Generates a Multipotent Stem Cell from a Fibroblast in Vitro
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 8,535,913Soluble composition for promoting hair growth produced by the hypoxic culture of fibroblast cells
Formerly held
In force
 · Low confidence
In forceLow confidence
US 10,538,736Conditioned Medium and Extracellular Matrix Compositions from Cells Cultured Under Hypoxic Conditions
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 11,274,276Conditioned Medium and Extracellular Matrix Compositions from Cells Cultured Under Hypoxic Conditions
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 8,530,415Repair And/Or Regeneration of Cells with a Composition Produced by Culturing Fibroblast Cells Under Hypoxic Conditions
Formerly held
In force
 · Low confidence
In forceLow confidence
US 9,512,403Conditioned Medium and Extracellular Matrix Compositions from Cells Cultured under Hypoxic Conditions for Methods of Treating Tissue Injury
Formerly held
In force
 · Low confidence
In forceLow confidence
US 11,597,703Caspase Inhibitors and Methods of Use Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,071,412Caspase Inhibitors and Methods of Use Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,447,497(S)-3-(2-(4-(BENZYL)-3-Oxopiperazin-1-YL)ACETAMIDO)-4-OXO-5-(2,3,5,6-Tetrafluorophenoxy)PENTANOIC Acid Derivatives and Related Compounds as Caspase Inhibitors for Treating Cardiovascular Diseases
Lapsed on the fee record
Ended Sep 20, 2026 · High confidence
Lapsed on the fee recordEnded Sep 20, 2026High confidence
10 of 23 patents shown.
Pro members see all 23.
Pro members: see all 23 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited